Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Fratta

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
CNS & Neurological Disorders Drug Targets|January 9, 2009
The endocannabinoid system: a new molecular target for the treatment of tobacco addictionMaria Scherma, Paola Fadda, Bernard Le Foll, et al.
Neuroscience Letters|February 12, 2008
Changed accumbal responsiveness to alcohol in rats pre-treated with nicotine or the cannabinoid receptor agonist WIN 55,212-2José Antonio López-Moreno, María Scherma, Fernando Rodríguez de Fonseca, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 25, 2007
Nicotinic alpha 7 receptors as a new target for treatment of cannabis abuseMarcello Solinas, Maria Scherma, Liana Fattore, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|November 29, 2019
Altered brain levels of arachidonic acid-derived inflammatory eicosanoids in a rodent model of anorexia nervosaRoberto Collu, Julia Maria Post, Maria Scherma, et al.
Frontiers in Neuroscience|February 20, 2018
Limited Access to a High Fat Diet Alters Endocannabinoid Tone in Female RatsValentina Satta, Maria Scherma, Fabiana Piscitelli, et al.
BMJ Open|May 28, 2017
Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational studyDiego Primavera, Mirko Manchia, Luca Deriu, et al.
Bioorganic & Medicinal Chemistry|April 9, 2002
N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes as mu-opioid receptor agonists. Effects on mu-affinity of arylalkenyl chain modificationsGérard A Pinna, Giorgio Cignarella, Giovanni Loriga, et al.
Behavioural Pharmacology|March 30, 2018
Sex-specific differences in cannabinoid-induced extracellular-signal-regulated kinase phosphorylation in the cingulate cortex, prefrontal cortex, and nucleus accumbens of Lister Hooded ratsMichela Rosas, Simona Porru, Valentina Giugliano, et al.
Biological Psychiatry|June 24, 2010
Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptorsMiriam Melis, Stefano Carta, Liana Fattore, et al.
Journal of Psychopharmacology (Oxford, England)|February 22, 2013
AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-takingIslam Gamaleddin, Mihail Guranda, Maria Scherma, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
CNS & Neurological Disorders Drug Targets|January 9, 2009
The endocannabinoid system: a new molecular target for the treatment of tobacco addictionMaria Scherma, Paola Fadda, Bernard Le Foll, et al.
Neuroscience Letters|February 12, 2008
Changed accumbal responsiveness to alcohol in rats pre-treated with nicotine or the cannabinoid receptor agonist WIN 55,212-2José Antonio López-Moreno, María Scherma, Fernando Rodríguez de Fonseca, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 25, 2007
Nicotinic alpha 7 receptors as a new target for treatment of cannabis abuseMarcello Solinas, Maria Scherma, Liana Fattore, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|November 29, 2019
Altered brain levels of arachidonic acid-derived inflammatory eicosanoids in a rodent model of anorexia nervosaRoberto Collu, Julia Maria Post, Maria Scherma, et al.
Frontiers in Neuroscience|February 20, 2018
Limited Access to a High Fat Diet Alters Endocannabinoid Tone in Female RatsValentina Satta, Maria Scherma, Fabiana Piscitelli, et al.
BMJ Open|May 28, 2017
Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational studyDiego Primavera, Mirko Manchia, Luca Deriu, et al.
Bioorganic & Medicinal Chemistry|April 9, 2002
N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes as mu-opioid receptor agonists. Effects on mu-affinity of arylalkenyl chain modificationsGérard A Pinna, Giorgio Cignarella, Giovanni Loriga, et al.
Behavioural Pharmacology|March 30, 2018
Sex-specific differences in cannabinoid-induced extracellular-signal-regulated kinase phosphorylation in the cingulate cortex, prefrontal cortex, and nucleus accumbens of Lister Hooded ratsMichela Rosas, Simona Porru, Valentina Giugliano, et al.
Biological Psychiatry|June 24, 2010
Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptorsMiriam Melis, Stefano Carta, Liana Fattore, et al.
Journal of Psychopharmacology (Oxford, England)|February 22, 2013
AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-takingIslam Gamaleddin, Mihail Guranda, Maria Scherma, et al.
Pageof 8